Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut - PubMed

Certain therapeutic microbes, including Bifidobacteria infantis (B. infantis) 35624 exert beneficial immunoregulatory effects by mimicking commensal-immune interactions; however, the value of these effects in patients with non-gastrointestinal inflammatory conditions remains unclear. In this study, …分類：pmid:23842110, PMC3744517, doi:10.4161/gmic.25487, Randomized Controlled Trial, David Groeger, Liam O'Mahony, Eamonn M M Quigley, Administration, Oral, Adolescent, Adult, Aged, Bifidobacterium / immunology*, C-Reactive Protein / analysis, Colitis, Ulcerative / immunology, Cytokines / blood, Double-Blind Method, Fatigue Syndrome, Chronic / immunology, Female, Gastrointestinal Tract / microbiology*, Humans, Immunosuppression Therapy, Male, Middle Aged, Placebos / administration & dosage, Probiotics / administration & dosage*, Psoriasis / immunology, Treatment Outcome, Young Adult, PubMed Abstract, NIH, NLM, NCBI, National Institutes of Health, National Center for Biotechnology Information, National Library of Medicine, MEDLINE...